Articles

  • 2 days ago | acsh.org | Chuck Dinerstein

    From failing air traffic control systems to the forgotten toll of COVID, add crystalline experiments inspired by childhood wonder and a deep dive into how disability innovations like the curb-cut effect shape society for everyone. The problems with air flights, with Newark, the poster child, speak to the years of neglect of our infrastructure. Countless administrations have tried to update systems, but other interests have prevailed, including the needs of the 1%.

  • 3 days ago | acsh.org | Chuck Dinerstein

    Medicare Advantage may lure seniors with slick perks and shiny star ratings, but many soon find themselves tangled in red tape and narrow networks. It’s a classic bait-and-switch: attract the healthy, frustrate the sick, and let the system quietly nudge the costly ones out the door.

  • 4 days ago | acsh.org | Cameron English |Chuck Dinerstein

    GLP-1 drugs like Ozempic are transforming weight loss and diabetes management. But no good deed goes unpunished, and the manufacturers of these medicines now face a wave of lawsuits, with plaintiffs claiming they weren't warned about rare but sometimes serious side effects. Is this litigation driven by solid evidence, or are the tort lawyers out for yet another unearned payday? Let's take a look.

  • 5 days ago | acsh.org | Cameron English |Chuck Dinerstein

    GLP-1 drugs like Ozempic are transforming weight loss and diabetes management. But no good deed goes unpunished, and the manufacturers of these medicines now face a wave of lawsuits, with plaintiffs claiming they weren't warned about rare but sometimes serious side effects. Is this litigation driven by solid evidence, or are the tort lawyers out for yet another unearned payday? Let's take a look.

  • 5 days ago | acsh.org | Chuck Dinerstein

    Ambiguous definitions and growing public concern fuel the debates over the health risks of ultra-processed foods (UPFs).

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →